R. Labrosse Et Al. , "Outcome of Hematopoietic Stem Cell Gene Therapy for Wiskott-Aldrich Syndrome," 61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) , vol.134, Florida, United States Of America, 2019
Labrosse, R. Et Al. 2019. Outcome of Hematopoietic Stem Cell Gene Therapy for Wiskott-Aldrich Syndrome. 61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) , (Florida, United States Of America).
Labrosse, R., Chu, J., Armant, M., van der Spek, J., Miggelbrink, A., Fong, J., ... Everett, J. K.(2019). Outcome of Hematopoietic Stem Cell Gene Therapy for Wiskott-Aldrich Syndrome . 61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Florida, United States Of America
Labrosse, Roxane Et Al. "Outcome of Hematopoietic Stem Cell Gene Therapy for Wiskott-Aldrich Syndrome," 61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Florida, United States Of America, 2019
Labrosse, Roxane Et Al. "Outcome of Hematopoietic Stem Cell Gene Therapy for Wiskott-Aldrich Syndrome." 61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) , Florida, United States Of America, 2019
Labrosse, R. Et Al. (2019) . "Outcome of Hematopoietic Stem Cell Gene Therapy for Wiskott-Aldrich Syndrome." 61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) , Florida, United States Of America.
@conferencepaper{conferencepaper, author={Roxane Labrosse Et Al. }, title={Outcome of Hematopoietic Stem Cell Gene Therapy for Wiskott-Aldrich Syndrome}, congress name={61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)}, city={Florida}, country={United States Of America}, year={2019}}